Brock Lesnar was issued a one year suspension by USADA for failing an out of competition and in-competition drug test for UFC 200. Lesnar will be reinstated on July 15, 2017.
A portion of the USADA press release announcing the sanction reads:
Lesnar, 39, tested positive for clomiphene and its metabolite, 4-hydroxyclomiphene, following an out-of-competition urine test conducted on June 28, 2016, and an in-competition urine test conducted on July 9, 2016, at UFC 200 in Las Vegas, Nev. Clomiphene is a prohibited substance in the category of Hormone and Metabolic Modulators and is prohibited at all times under the UFC Anti-Doping Policy, which has adopted the WADA Prohibited List.
Last month, Lesnar entered into a settlement with the Nevada State Athletic Commission regarding the same drug test failure. He received a one-year sentence and $250,000 fine.
The drug has the ability to double testosterone levels. It is generally used as a fertility drug that causes the pituitary gland to release hormones. Notably, Lyoto Machida’s suspension of 18 months was for 7-keto-DHEA which helps burn fat.
Payout Perspective:
The suspension was more or less expected after Lesnar settled with the NSAC. Of course, the disparity in suspensions we mention with Lyoto Machida have to be frustrating. The drug taken by Lesnar could aid him in fighting and I’m sure Mark Hunt its upset about this suspension. On the other hand, Machida’s banned substance helps burn fat so that you can make weight. The suspension reflect the issues with the UFC anti-doping policy overseen by USADA.
Leave a Reply